Menu

CME Corner

Active Programs

Systemic Sclerosis Interstitial Lung Disease: Early Diagnosis and Comprehensive Management

Interstitial lung disease (ILD) is a frequent complication of the autoimmune disorder systemic sclerosis (SSc). SSc-ILD remains a challenging condition to identify, treat, and manage. Early identification of ILD in patients with SSc is critical so that treatment can be initiated as soon as possible. However, utilization of optimal screening and diagnosis strategies is low among healthcare provider ...

  • Online Presentation Online Presentation
  • ACCME

Decoding Interstitial Lung Disease: Identifying and Managing Progressive Phenotypes

Interstitial lung disease (ILD) comprises more than 130 distinct lung disorders. Some forms of ILD, including connective tissue disease-associated ILD (CTD-ILD), chronic hypersensitivity pneumonitis (CHP), and fibrosing types of ILD such as fibrotic nonspecific interstitial pneumonia (fNSIP), follow a particularly aggressive course. This activity will address the timely identification and treatmen ...

  • Online Presentation
  • ACCME

Expired Programs

Evolving Standards of Care in Metastatic Prostate Cancer

For patients with metastatic prostate cancer (mPRCA), the number of metastases has prognostic and therapeutic implications. Clinicians who treat patients with mPRCA need to recognize patients with oligometastatic prostate cancer and be aware that management of patients with fewer than 5 metastases is different from that of patients with polymetastatic disease. Recommendations for the initial manag ...

  • Online Presentation Online Presentation
  • ACCME

Identifying and Diagnosing Interstitial Lung Disease

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. This activity will examine strategies for identifying and accurately diagnosing ILD. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation
  • ACCME
Main Menu
EDITOR'S PICKS